Skip to content
TrialScanner

NCT03926793

Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension

Phase 1CompletedGOSSLead

Registry record

Lead sponsor
GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
Conditions
Pulmonary Arterial Hypertension
Primary completion
May 5, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03926793 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03926793: Clinical Study of Inhaled... | TrialScanner